Nuclei Isolation from Adult Mouse Kidney for Single-Nucleus RNA-Sequencing
September 20th, 2021
6.7K views
Here, we present a protocol to isolate high-quality nuclei from frozen mouse kidneys that improve the representation of medullary kidney cell types and avoids the gene expression artifacts from enzymatic tissue dissociation.
Overview
This article presents a protocol for isolating high-quality nuclei from frozen mouse kidneys, enhancing the representation of medullary kidney cell types while minimizing gene expression artifacts from enzymatic dissociation.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Gene Expression
Background
- Understanding gene expression at a single-cell level is crucial for studying complex tissues.
- Traditional methods may introduce artifacts that affect data quality.
- This protocol aims to provide a reliable alternative for tissue processing.
- It is applicable to various tissue types beyond kidneys.
Purpose of Study
- To develop a method for high-quality nuclei isolation from mouse kidneys.
- To improve the accuracy of gene expression data from kidney cell types.
- To reduce protocol-related artifacts in gene expression analysis.
Methods Used
- Dissection of frozen kidney tissue to obtain a representative sample.
- Use of RNA stabilization solution to preserve RNA integrity.
- Homogenization and centrifugation to isolate nuclei.
- Assessment of nuclei quality through gene expression analysis.
Main Results
- A total of 20,000 genes were detected in 6,000 nuclei.
- Median values of 1,600 genes and 2,800 unique molecular identifiers were observed per nucleus.
- Gene expression patterns were visualized using dot plots and t-SNE plots.
- Cell type ratios were calculated to analyze kidney cell populations.
Conclusions
- The protocol effectively isolates high-quality nuclei from kidney tissues.
- It minimizes artifacts and enhances gene expression data reliability.
- This method can be adapted for use with various tissue types.
Frequently Asked Questions
What is the main advantage of this protocol?
The protocol improves the quality of nuclei isolation and reduces gene expression artifacts compared to traditional methods.
Can this method be applied to other tissues?
Yes, the protocol is adaptable for use with various tissue types beyond mouse kidneys.
How does the RNA stabilization solution work?
It preserves RNA integrity during the tissue processing, preventing degradation.
What are the key steps in the nuclei isolation process?
Key steps include tissue dissection, homogenization, centrifugation, and nuclei quality assessment.
What metrics are used to assess nuclei quality?
Metrics include the number of detected genes, unique molecular identifiers, and visualization of gene expression patterns.
Executive Industry Relevance
This protocol enables high-fidelity single-nucleus transcriptomics from frozen kidney tissue, addressing a key limitation in renal drug discovery where enzymatic dissociation biases cortical cell representation and obscures medullary targets. By preserving the corticomedullary axis and minimizing transcriptional stress, it improves target validation confidence for diuretic, fibrotic, and metabolic kidney disease programs. The method supports reproducible, scalable nuclei isolation for downstream screening and biomarker discovery in preclinical renal research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses across the full corticomedullary axis, reducing bias toward cortical cell types in target identification.
- Operational Value: Provides a standardized nuclei isolation workflow compatible with frozen biobanked samples, increasing sample availability for target de-risking.
Screening & Assay Development
- Scientific Value: Generates high-quality nuclei with low mitochondrial read fractions, supporting reliable single-nucleus RNA-seq for compound screening in kidney disease models.
- Operational Value: Delivers consistent nuclei yields (6,000 nuclei per sample) with median 1,600 genes and 2,800 UMIs per nucleus, enabling assay standardization across discovery campaigns.
Translational & Preclinical Research
- Scientific Value: Facilitates disease-relevant system modeling by capturing medullary cell populations critical for studying concentration-dependent drug effects in the kidney.
- Operational Value: Supports translational biomarker alignment by preserving native gene expression profiles without dissociation-induced artifacts.
Pipeline & Workflow Integration
The method fits within the discovery continuum from hypothesis-driven target validation to lead optimization, providing nuclei preparation for genomic screening in kidney disease models.
- Discovery Biology: Supports pathway clarification and mechanistic de-risking by enabling unbiased cell type profiling across cortex, outer medulla, and inner medulla.
- Screening: Delivers quantitative, reproducible nuclei isolation outputs suitable for high-throughput single-nucleus transcriptomic screening.
- Analytics: Provides gene expression readouts (UMI counts, mitochondrial fraction) and clustering data (t-SNE, dot plots) to compare treatment conditions and genetic perturbations.
- Translational Research: Connects discovery to preclinical continuity by maintaining corticomedullary architecture relevant to drug distribution and response.
- Enterprise Reuse: Establishes a reusable nuclei isolation platform applicable to multiple renal disease models and tissue archives.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target selection by reducing mechanistic ambiguity from dissociation bias and transcriptional artifacts.
- Operational Value: Enhances reproducibility and scalability through standardized, RNase-protected nuclei isolation from frozen tissue.
- Strategic Value: Improves go/no-go decisions by enabling comprehensive cell type profiling that reduces late-stage biological risk in renal programs.
- Portfolio Impact: Supports risk-adjusted prioritization through improved representation of medullary targets in drug target atlases.
Implementation Considerations
- Requires expertise in tissue handling, nuclei isolation, and single-nucleus RNA-seq library preparation.
- Dependent on access to cryostat, centrifuge with swinging-bucket rotor, RNase inhibitors, and gradient centrifugation equipment.
- Necessitates cross-team standardization of tissue dissection, freezing, and lysis protocols to ensure consistency across sites.
- Adaptation to other tissues requires optimization of dissection timing and lysis buffer conditions based on tissue density and RNAse sensitivity.
- Practical limitations include the need for RNA stabilization prior to freezing and careful gradient handling to avoid nuclei loss or debris contamination.
Biopharma FAQs
Why does nuclei isolation improve target validation in kidney discovery?
Nuclei isolation from frozen kidney tissue preserves the corticomedullary axis and avoids enzymatic dissociation bias, enabling unbiased profiling of medullary and cortical cell types. This improves target validation confidence by reducing false negatives in underrepresented populations such as inner medulla cells critical for drug response.
How does tissue dissection support independent variable isolation in renal screening?
Dissection of a central kidney piece containing cortex, outer medulla, and inner medulla ensures the independent variable (tissue region) is fully represented, eliminating cortical overrepresentation. This allows accurate assessment of gene expression changes across the full axis in response to genetic or pharmacological perturbations.
What quantitative measurements enable nuclei quality assessment in this protocol?
Nuclei quality is assessed by plotting genes detected against transcripts (UMIs) and coloring by mitochondrial read fraction, with 20,000 genes detected in 6,000 nuclei and median values of 1,600 genes and 2,800 UMIs per nucleus. Low mitochondrial reads and high gene complexity indicate minimal transcriptional stress and high data fidelity.
Why are replication requirements important for cross-functional collaboration in renal omics?
Replication ensures consistent nuclei yields and quality metrics across experiments, which is essential for comparing data between discovery, preclinical, and translational teams. Standardized outputs (e.g., 6,000 nuclei per sample) enable reliable integration of single-nucleus data into multi-omics pipelines.
What statistical analysis capabilities are required before implementing this nuclei isolation workflow?
Implementation requires the ability to analyze gene expression distributions, mitochondrial fraction, and UMI counts per nucleus to assess data quality. Downstream analysis must support clustering (t-SNE), marker visualization (dot plots), and cell type ratio calculations (e.g., proximal tubule to thick ascending limb) to interpret renal cell population changes.
